Skip to main content
SpringerLink
Log in

Giant Hemangioma/Kasabach-Merritt Syndrome

  • Chapter
Radiotherapy for Non-Malignant Disorders

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

About 10% of neonates present with angioma in the first days or weeks of life. The main diagnostic and therapeutic problem is the correct differentiation of the various forms of vascular anomalies, which also defines the treatment strategy [21]. Especially the terms ‘hemangioma’ and Vascular malformation’ should be strictly separated from each other. Though both are caused by a disturbance in embryonic vessel development, vascular malformations already exist at the time of birth, while hemangiomas develop during the first days or weeks of life [19]. The initial clinical presentation can be very similar, so that exact history taking and clinical description are of great importance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barlow CF, Priebe CJ, Mulliken JB (1998) Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 132:527–530

    Article  PubMed  CAS  Google Scholar 

  2. Blei F, Isakoff M, Deb G (1997) The response of parotid hemangiomas to the use of systemic interferon alfa-2a or cortical steroids. Arch Otolaryngol Head Neck Surg 123:841–844

    PubMed  CAS  Google Scholar 

  3. Chang E, Boyd A, Nelson CC et al (1997) Successful treatment of infant hemangiomas with interferon alpha-2b. J Pediatr Hematol Oncol 19:237–244

    Article  PubMed  CAS  Google Scholar 

  4. Cirelli R, Tyring SK (1995) Major therapeutic uses of interferons. Clin Immunother 3:27–87

    Google Scholar 

  5. Collins Finn M, Glowacki J, Mulliken JB (1983) Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 18:6

    Article  Google Scholar 

  6. David TJ, Evans DIK, Stevens RF (1983) Haemangioma with thrombocytopenia (Kasabach-Merritt syndrome). Arch Dis Child 58:1022–1023

    Article  PubMed  CAS  Google Scholar 

  7. Donaldson SS, Chassagne D, Sancho-Garnier H et al (1979) Results of 90Y interstitial therapy: a retrospective study. Int J Radiat Oncol Biol Phys 5:1–11

    PubMed  CAS  Google Scholar 

  8. Dutton SC, Plowman PN (1991) Paediatric haemangiomas: the role of radiotherapy. Br J Radiol 64:261–269

    PubMed  CAS  Google Scholar 

  9. El-Dessouky M, Azmy AF, Raine PA, Young DG (1988) Kasabach-Merritt syndrome. J Pediatr Surg 23:109–111

    Article  PubMed  CAS  Google Scholar 

  10. Enjolras O, Riche MC, Merland JJ, Escande JP (1990) Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 85:491–498

    PubMed  CAS  Google Scholar 

  11. Ezekowitz RAB, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456–1463

    PubMed  CAS  Google Scholar 

  12. Fost NC, Easterly NB (1968) Successful treatment of juvenile hemangiomas with prednisone. Pediatrics 72:351–357

    Article  CAS  Google Scholar 

  13. Furst CJ, Lundell M, Holm LE (1987) Radiation therapy of hemangiomas, 1909-1959: a cohort based on 50 years of clinical practice at Radiumhemmet, Stockholm. Acta Oncol 26:33–36

    Article  PubMed  CAS  Google Scholar 

  14. Furst CJ, Lundell M, Holm L, Silversward C (1988) Cancer incidence after radiotherapy for skin hemangioma: a retrospective cohort study in Sweden. J Natl Cancer Inst 80:1387–1392

    Article  PubMed  CAS  Google Scholar 

  15. Greinwald JH Jr, Burke DK, Bonthius DJ et al (1999) An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 125:21–27

    PubMed  Google Scholar 

  16. Hesselmann S, Micke O, Marquardt T, Baas S, Brämswig JH, Harms E, Willich N (2002) Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha. Br J Radiol 75:180–184

    PubMed  CAS  Google Scholar 

  17. Jones GJ, Itri LM (1986) Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients. Cancer 57:1709–1715

    Article  PubMed  CAS  Google Scholar 

  18. Kasabach HH, Merritt KK (1940) Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child 59:1063–1070

    Google Scholar 

  19. Klima-Lange D (2000) Gefässanomalien im Kindesalter und ihre Behandlung. Pädiatrie 4/2000:19–22

    Google Scholar 

  20. Larsen EC, Zinkham WH, Eggleston JC, Zitelli BJ (1987) Kasabach-Merritt syndrome: therapeutic consideration. Pediatrics 79:971–980

    PubMed  CAS  Google Scholar 

  21. Low DW (1994) Hemangiomas and vascular malformations. Semin Pediatr Surg 3:40–61

    PubMed  CAS  Google Scholar 

  22. MacArthur CJ, Senders CW, Katz J (1995) The use of interferon alfa-2a for life-threatening hemangiomas. Arch Otolaryngol Head Neck Surg 121:690–693

    PubMed  CAS  Google Scholar 

  23. Martins AG (1970) Hemangioma and thrombocytopenia. J Pediatr Surg 5:641

    Article  PubMed  CAS  Google Scholar 

  24. Mitsuhashi N, Masaya F, Sakurai H, Takahashi T et al (1997) Outcome of radiation therapy for patients with Kasabach-Merritt syndrome. Int J Radiat Oncol Biol Phys 39:467–473

    PubMed  CAS  Google Scholar 

  25. Ogino I, Torikai K, Kobayasi S, Aida N, Hata M, Kigasawa H (2001) Radiation therapy for life-or function-threatening infant hemangioma. Radiology 218(3):834–839

    PubMed  CAS  Google Scholar 

  26. Ortel TL, Onorato JJ, Bedrosian CL, Karfman RE (1988) Antifibrinolytic therapy in the management of the Kasabach-Merritt syndrome. Am J Hematol 29:44–48

    Article  PubMed  CAS  Google Scholar 

  27. Proske H, Pfab R (1993) Indikationsstellung zur Hochvoltbestrahlung kavernöser ... hemangioma of the Liver. Radiotherapy and Oncology 29 45–50

    Article  Google Scholar 

  28. Schild SE, Buskirk SJ, Frick LM, Cupps RE (1991) Radiotherapy for large symptomatic hemangiomas. Int J Radiat Oncol Biol Phys 21:729–735

    PubMed  CAS  Google Scholar 

  29. Sealy R, Barry L, Buret E et al (1989) Cavernous haemangioma of the head and neck in the adult. J R Soc Med 82:198–201

    PubMed  CAS  Google Scholar 

  30. Takato T, Komuro Y, Yonehara Y (1993) Giant hemangioma of the parotid gland associated with Kasabach-Merritt syndrome: a case report. J Oral Maxillofac Surg. 51(4):425–428. No abstract available.

    PubMed  CAS  Google Scholar 

  31. Warrell RP Jr, Kempin SJ (1985) Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med 313:309–312

    PubMed  Google Scholar 

  32. White C (1990) Treatment of hemangiomatosis with recombinant interferon alfa. Semin Hematol 27:15–22

    PubMed  CAS  Google Scholar 

  33. White CW, Sondheimer HM, Croach EC et al (1989) Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 320:1197–1200

    Article  PubMed  CAS  Google Scholar 

  34. Yoshikawa M, Hayashi T, Sato T, Akiba T et al (1987) A case of pericardial hemangioma with consumption coagulopathy cured by radiotherapy. Pediatr Radiol 17:149–150

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiotherapy and Radiation Oncology, University of Muenster, Albert-Schweitzer-Str. 33, 48149, Muenster, Germany

    Patrick Schueller MD & Stefan Hesselmann MD

  2. PD, Department of Radiation Therapy and Radiation Oncology, Franziskus Hospital, Kiskerstraße 26, 33615, Bielefeld, Germany

    Oliver Micke MD

Authors
  1. Patrick Schueller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefan Hesselmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Oliver Micke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology and Therapeutic Radiology, Alfried-Krupp-Hospital, Alfried-Krupp-Strasse 21, Postfach 10 22 43, 45117, Essen, Germany

    Michael Heinrich Seegenschmiedt MD (Professor) (Professor)

  2. Strahlenklinik Klinikum Duisburg, Zu den Rehwiesen 9, 47055, Duisburg, Germany

    Hans-Bruno Makoski MD (Professor) (Professor)

  3. Department of Radiation Biology, St. Bartolomew’s Medical College, Charterhouse Square, London, EC1M 6BQ, UK

    Klaus-Rüdiger Trott MD (Professor) (Professor)

  4. Hylda Cohn/American Cancer Society, USA

    Luther W. Brady MD (Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor) (Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor)

  5. College of Medicine, Drexel University, Broad & Vine Sts., Mail Stop 200, Philadelphia, PA, 19102-1192, USA

    Luther W. Brady MD (Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor) (Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schueller, P., Hesselmann, S., Micke, O. (2008). Giant Hemangioma/Kasabach-Merritt Syndrome. In: Seegenschmiedt, M.H., Makoski, HB., Trott, KR., Brady, L.W. (eds) Radiotherapy for Non-Malignant Disorders. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68943-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68943-0_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-62550-6

  • Online ISBN: 978-3-540-68943-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation